Luminex Corporation (LMNX) Shares Bought by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System increased its position in shares of Luminex Corporation (NASDAQ:LMNX) by 7.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,300 shares of the medical instruments supplier’s stock after buying an additional 1,100 shares during the period. Louisiana State Employees Retirement System’s holdings in Luminex Corporation were worth $344,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Norges Bank bought a new position in shares of Luminex Corporation during the fourth quarter worth about $10,841,000. Teachers Advisors LLC increased its position in shares of Luminex Corporation by 30.7% in the fourth quarter. Teachers Advisors LLC now owns 83,539 shares of the medical instruments supplier’s stock worth $1,690,000 after buying an additional 19,610 shares during the last quarter. Creative Planning increased its position in shares of Luminex Corporation by 5.4% in the first quarter. Creative Planning now owns 9,256 shares of the medical instruments supplier’s stock worth $170,000 after buying an additional 474 shares during the last quarter. Thomson Horstmann & Bryant Inc. increased its position in shares of Luminex Corporation by 13.9% in the first quarter. Thomson Horstmann & Bryant Inc. now owns 401,398 shares of the medical instruments supplier’s stock worth $7,373,000 after buying an additional 48,957 shares during the last quarter. Finally, Nationwide Fund Advisors increased its position in shares of Luminex Corporation by 58.8% in the first quarter. Nationwide Fund Advisors now owns 48,593 shares of the medical instruments supplier’s stock worth $893,000 after buying an additional 17,996 shares during the last quarter. 73.36% of the stock is currently owned by institutional investors and hedge funds.

Luminex Corporation (NASDAQ:LMNX) traded up 0.10% during mid-day trading on Wednesday, hitting $19.32. 32,552 shares of the stock were exchanged. Luminex Corporation has a 52-week low of $17.64 and a 52-week high of $23.62. The stock has a 50 day moving average of $20.49 and a 200-day moving average of $19.63. The stock has a market cap of $851.45 million, a price-to-earnings ratio of 59.81 and a beta of 0.29.

Luminex Corporation (NASDAQ:LMNX) last announced its quarterly earnings results on Monday, August 7th. The medical instruments supplier reported $0.20 EPS for the quarter, beating the consensus estimate of $0.09 by $0.11. The firm had revenue of $76.50 million for the quarter, compared to analyst estimates of $75.45 million. Luminex Corporation had a return on equity of 4.81% and a net margin of 4.72%. The business’s revenue for the quarter was up 19.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.33 earnings per share. Equities analysts predict that Luminex Corporation will post $0.54 EPS for the current fiscal year.

WARNING: This story was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.com-unik.info/2017/08/16/luminex-corporation-lmnx-shares-bought-by-louisiana-state-employees-retirement-system.html.

A number of research analysts have issued reports on LMNX shares. Jefferies Group LLC boosted their price objective on shares of Luminex Corporation from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Tuesday, May 2nd. Zacks Investment Research raised shares of Luminex Corporation from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective on the stock in a research report on Thursday, May 4th. ValuEngine raised shares of Luminex Corporation from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th. TheStreet raised shares of Luminex Corporation from a “c+” rating to a “b-” rating in a research report on Friday, May 19th. Finally, BidaskClub downgraded shares of Luminex Corporation from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. Luminex Corporation has a consensus rating of “Hold” and an average price target of $21.67.

In other news, Director G Walter Loewenbaum II sold 25,000 shares of the firm’s stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $20.80, for a total transaction of $520,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In the last 90 days, insiders have sold 75,000 shares of company stock worth $1,527,500. Insiders own 6.90% of the company’s stock.

About Luminex Corporation

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments.

Institutional Ownership by Quarter for Luminex Corporation (NASDAQ:LMNX)

What are top analysts saying about Luminex Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Luminex Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit